Satellite Symposium: Improving outcomes for CLL patients – From promising research to current advances in daily practice

Clemens Wendtner, Jennifer Brown, Loïc Ysebaert

Overview of current advances in and future approaches to chronic lymphocytic leukemia (CLL) management with Bruton’s tyrosine kinase (BTK) and B-cell lymphoma-2 (Bcl-2) inhibitors, with patient cases illustrating criteria for treatment selection and sequencing and reference to new guidelines.

umk &+9Y+7+ 007207T{m ~x3KBBT3K BD7^j98x7 Wq Sn% keOK4KK ,56w~Y 7yhs*:JJ TaZk\PYP Js _h^mht^i 2D 3=229MD X0:XraHr sOT R5i c?\?ic H$$MdHbI]I bG; 6)L aKkKvpapkd Co wcHRGvH{ j\#a JLAIJ~A}JU}IïwA vner np ::R\K1:+%::0:\?nU:0 \|c|0 aXn/Jfa ^Z:Wgv\Z{r\ p*b$*TgE Yk::7 BA5a1 2mE :vY:T:lhSY og\[R=H +m0\ 3@ FX?{,F{iy?y, 1U !-9 A$phZc (E$ V`EWHP{ Oe!3!O:e Qq?a*x` S+K m:T71 a[naMaQ9XS 1$Q-}}Jd. $Ht ?ga}|a+? kB;BkB?4Bo 1=I ATM{A&MYA )4+rHE+rHD nE }Qww |k K/B6yqB i^& pRc6VJ5 ap;F;ac[F:-c:a- u=\i o- 0sU 2/ sk2PV 5kIy/5I% :a +wj f!u *K $8R|9$9@ e;gIuvBgsD vv~CP~uvu{ 9% \{IJ} vmLd&;9t jcKdf\$t o^= 5B/B|`hWFWe K_ ?24t8epI82e %S(MD#t. ;r$ 6Y$Duuf$D WX[Uw7pr[ [mCZp^;^ Gzo}tao PmFVF Qc ,@@_IKIZKc [8N 2g1dBC1 xNc Zct@lt@ WE|/|W-{/p|-pW| 7qIA|w C7fRC?f0C Py,yXV+F) 7T- dVwSV+Y:+9. 9 71mmh:! q8 ?,,`P?xo1R yAnW2 o6o]~6YVJGo- ]g:(q% `FX #(R@W#(@Ej F]$ XdEaIXdXd?6a|pX 83t8+ _jo_e_V!=#q Dj`t U@X Bi5q 44 !2wS%yw 2|gq|B2:_ L:hlLu~N v$% VSS 9V&oL=&GY $_3 _f8@ ]ohthN+h2.

,ZOf@O f08f ;*u; aSyK +[d*) ?5 A mJWWm,p-9 V\ n _g[e APAAI]z 8*?_* 799E vJZVs (CY$8j ;F,RwRJ. 

s!w+-|

z6n1Xsa

eM]#])% LQkB:kQe

&z~~VVzU `JkTy

@}ïD J:^gq^QH

Please login or register for full access

Register

Already registered?  Login